Literature DB >> 1631564

Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).

T Matsuo1, K Kario, K Kodama, S Okamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1631564     DOI： 10.1055/s-2007-1002421

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  3 in total

Review 1.  A synopsis of the clinical uses of argatroban.

Authors:  M Moledina; M Chakir; P J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300

2.  Effect of Thrombin Inhibition on Patients with Peripheral Arterial Obstructive Disease: A Multicenter Clinical Trial of Argatroban.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

3.  Argatroban During Percutaneous Transluminal Coronary Angioplasty: Results of a Dose-Verification Study.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.